Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.
Martínez-Domínguez SJ, García-Mateo S, Gargallo-Puyuelo CJ, Gallego-Llera B, Callau P, Mendi C, Arroyo-Villarino MT, Simón-Marco MÁ, Ampuero J, Gomollón F. Martínez-Domínguez SJ, et al. Among authors: gomollon f. Inflamm Bowel Dis. 2023 Aug 22:izad175. doi: 10.1093/ibd/izad175. Online ahead of print. Inflamm Bowel Dis. 2023. PMID: 37607330
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients.
Chaparro M, Ordás I, Cabré E, Garcia-Sanchez V, Bastida G, Peñalva M, Gomollón F, García-Planella E, Merino O, Gutiérrez A, Esteve M, Márquez L, Garcia-Sepulcre M, Hinojosa J, Vera I, Muñoz F, Mendoza JL, Cabriada JL, Montoro MA, Barreiro-de Acosta M, Ceña G, Saro C, Aldeguer X, Barrio J, Maté J, Gisbert JP. Chaparro M, et al. Among authors: gomollon f. Inflamm Bowel Dis. 2013 Jun;19(7):1404-10. doi: 10.1097/MIB.0b013e318281f28f. Inflamm Bowel Dis. 2013. PMID: 23665964
Bioequivalence studies with anti-TNF biosimilars.
Gimeno-Gracia M, Gargallo-Puyuelo CJ, Gomollón F. Gimeno-Gracia M, et al. Among authors: gomollon f. Expert Opin Biol Ther. 2019 Oct;19(10):1031-1043. doi: 10.1080/14712598.2019.1561851. Epub 2018 Dec 31. Expert Opin Biol Ther. 2019. PMID: 30574813 Review.
Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.
Cañete F, Mañosa M, Casanova MJ, González-Sueyro RC, Barrio J, Bermejo F, Nos P, Iglesias-Flores E, García-Planella E, Pérez-Calle JL, Vicente R, Vera M, Ramos L, Rivero M, De Francisco R, Montserrat A, Benítez O, Navarro P, Taxonera C, Hinojosa E, Márquez-Mosquera L, Navarro-Llavat M, Ramírez-de la Piscina P, Gomollón F, Rodríguez-Alonso L, Núñez-Alonso A, Fernández-Salazar L, Almela P, Ríos León R, De Castro L, Gisbert JP, Ricart E, Cabré E, Domènech E; ENEIDA registry by GETECCU. Cañete F, et al. Among authors: gomollon f. Inflamm Bowel Dis. 2019 Oct 18;25(11):1862-1870. doi: 10.1093/ibd/izz084. Inflamm Bowel Dis. 2019. PMID: 31006801
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
Casanova MJ, Chaparro M, Mínguez M, Ricart E, Taxonera C, García-López S, Guardiola J, López-San Román A, Iglesias E, Beltrán B, Sicilia B, Vera MI, Hinojosa J, Riestra S, Domènech E, Calvet X, Pérez-Calle JL, Martín-Arranz MD, Aldeguer X, Rivero M, Monfort D, Barrio J, Esteve M, Márquez L, Lorente R, García-Planella E, de Castro L, Bermejo F, Merino O, Rodríguez-Pérez A, Martínez-Montiel P, Van Domselaar M, Alcaín G, Domínguez-Cajal M, Muñoz C, Gomollón F, Fernández-Salazar L, García-Sepulcre MF, Rodríguez-Lago I, Gutiérrez A, Argüelles-Arias F, Rodriguez C, Rodríguez GE, Bujanda L, Llaó J, Varela P, Ramos L, Huguet JM, Almela P, Romero P, Navarro-Llavat M, Abad Á, Ramírez-de la Piscina P, Lucendo AJ, Sesé E, Madrigal RE, Charro M, García-Herola A, Pajares R, Khorrami S, Gisbert JP. Casanova MJ, et al. Among authors: gomollon f. Inflamm Bowel Dis. 2020 Mar 4;26(4):606-616. doi: 10.1093/ibd/izz192. Inflamm Bowel Dis. 2020. PMID: 31504569 Free article.
Inflammatory bowel disease and the risk of cardiovascular diseases.
Nuñez P, García Mateo S, Quera R, Gomollón F. Nuñez P, et al. Among authors: gomollon f. Gastroenterol Hepatol. 2021 Mar;44(3):236-242. doi: 10.1016/j.gastrohep.2020.09.002. Epub 2020 Oct 20. Gastroenterol Hepatol. 2021. PMID: 33223261 Review. English, Spanish.
271 results